Participants 59 88 4
adults with autistic disorder
Participants 496 566 7
Thirty adults with autistic disorder completed a 12-week double-blind,
Participants 764 900 4
Eight (53%) of 15 patients in the fluvoxamine-treated group were categorized as responders compared with none of 15 in the placebo group
